X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (31) 31
humans (24) 24
index medicus (23) 23
female (16) 16
male (16) 16
middle aged (16) 16
aged (15) 15
chemotherapy (15) 15
adult (11) 11
cancer (11) 11
lung cancer (11) 11
medicine and health sciences (11) 11
hematology, oncology and palliative medicine (10) 10
treatment outcome (10) 10
quality of life (9) 9
radiotherapy (9) 9
care and treatment (8) 8
mesothelioma (8) 8
neoplasm staging (8) 8
respiratory system (8) 8
aged, 80 and over (7) 7
lung neoplasms - pathology (7) 7
surgery (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
cisplatin (6) 6
lung cancer, non-small cell (6) 6
lung neoplasms - drug therapy (6) 6
lung neoplasms - therapy (6) 6
palliative care (6) 6
patients (6) 6
research (6) 6
survival (6) 6
trial (6) 6
analysis (5) 5
non-small cell lung cancer (5) 5
nsclc (5) 5
randomized controlled-trial (5) 5
studies (5) 5
carcinoma, non-small-cell lung - drug therapy (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
cisplatin - administration & dosage (4) 4
combined modality therapy (4) 4
drug administration schedule (4) 4
lung neoplasms - radiotherapy (4) 4
lung-cancer (4) 4
management (4) 4
mesothelioma - therapy (4) 4
oncology, experimental (4) 4
protein kinase inhibitors - adverse effects (4) 4
protein kinase inhibitors - therapeutic use (4) 4
toxicity (4) 4
administration, oral (3) 3
advanced cancer (3) 3
antineoplastic agents - therapeutic use (3) 3
cancer therapies (3) 3
carboplatin (3) 3
carcinoma, non-small-cell lung - radiotherapy (3) 3
carcinoma, non-small-cell lung - surgery (3) 3
cell lung-cancer (3) 3
chemoradiotherapy (3) 3
clinical trials as topic (3) 3
combined modality (3) 3
disease progression (3) 3
disease-free survival (3) 3
extrapleural pneumonectomy (3) 3
follow-up studies (3) 3
guidelines (3) 3
health aspects (3) 3
hospice care (3) 3
lung neoplasms - mortality (3) 3
lung neoplasms - surgery (3) 3
metaanalysis (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
phase-ii trial (3) 3
pleural neoplasms - therapy (3) 3
prognosis (3) 3
protein kinase inhibitors - administration & dosage (3) 3
pulmonary/respiratory (3) 3
quality-of-life (3) 3
quinazolines - administration & dosage (3) 3
respiratory tract diseases (3) 3
retrospective studies (3) 3
supportive care (3) 3
therapy (3) 3
time factors (3) 3
treatment (3) 3
tumors (3) 3
tyrosine (3) 3
antineoplastic agents - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
belgium (2) 2
belgium - epidemiology (2) 2
carboplatin - administration & dosage (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
carcinoma, non-small-cell lung - therapy (2) 2
chemoradiotherapy - methods (2) 2
clinical trials (2) 2
clinical-trials (2) 2
combination (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 8, pp. 1116 - 1125
Journal Article
Heart, ISSN 1355-6037, 07/2017, Volume 103, Issue 13, pp. 1053 - 1053
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. e222 - e222
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 06/2018, Volume 8, p. 188
In a patient with a medical history of cancer, the most probable diagnosis of an (18)FDG-avid pulmonary mass combined with intracranial abnormalities on brain... 
Brain metastasis | Lung cancer | Aspergillosis | Brain abscess | Brain neoplasms | Differential diagnosis | Lung neoplasms | DIAGNOSIS | differential diagnosis | lung neoplasms | MRI | brain neoplasms | COMPUTED-TOMOGRAPHY | lung cancer | PULMONARY ASPERGILLOSIS | ONCOLOGY | aspergillosis | BRAIN METASTASES | brain abscess | brain metastasis | Case studies | Care and treatment | Diagnosis | Metastasis
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 12/2017, Volume 120, pp. 234 - 236
The publisher regrets that an incomplete version of Fig. 2 was published. The full version of Fig. 2 is shown below. The publisher would like to apologise for... 
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2015, Volume 76, Issue 4, pp. 843 - 851
To determine the maximum tolerated dose (MTD) of volasertib, a Polo-like kinase inhibitor, combined with afatinib, an oral irreversible ErbB family blocker, in... 
Advanced cancer | Medicine & Public Health | Afatinib | Phase I trial | Oncology | Cancer Research | Pharmacology/Toxicology | Volasertib | PLK | EGFR | OPEN-LABEL | KINASE INHIBITOR | CANCER-THERAPY | TRIAL | DOSE-ESCALATION | LUNG-CANCER | ONCOLOGY | BI 6727 | MALIGNANCIES | TARGETS | PHARMACOLOGY & PHARMACY | RECEPTORS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Pteridines - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Pteridines - adverse effects | Male | Pteridines - administration & dosage | Protein Kinase Inhibitors - adverse effects | Dose-Response Relationship, Drug | Neoplasm Metastasis | Drug Interactions | Neoplasms - blood | Adult | Female | Quinazolines - administration & dosage | Neutropenia - chemically induced | Protein Kinase Inhibitors - pharmacokinetics | Severity of Illness Index | Drug Administration Schedule | Administration, Oral | Thrombocytopenia - physiopathology | Pteridines - pharmacokinetics | Thrombocytopenia - chemically induced | Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Neoplasm Staging | Neoplasms - pathology | Cohort Studies | Neutropenia - physiopathology | Tumors
Journal Article
Journal Article